Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Ketones [NA]
A terminated University of Michigan clinical trial evaluated brain metabolism of small-chain fatty acids using ketone-based therapy in Parki…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Stereotactic Intracerebral Injection of IPSC-DAPs in Patients with Parkinson's Disease [Phase 1]
Phase 1 clinical trial evaluating stereotactic intracerebral injection of IPSC-DAPs for Parkinson disease; currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Light Therapy in Parkinson's Disease [NA]
A clinical trial is evaluating light therapy for Parkinson's disease and related sleep and circadian rhythm disorders and is currently recru…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Minimal Electrophysiology and Imaging Enhanced Deep Brain Stimulation [NA]
A clinical trial update shows a study of minimal electrophysiology and imaging enhanced deep brain stimulation for Parkinson disease that is…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Real-Time Levodopa Level Monitoring in Parkinson Disease [NA]
A clinical trial update indicates recruiting status for a study on real-time levodopa level monitoring in Parkinson's disease. The sponsor i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: The Effect of Different Types of Focus Instructions in Parkinson's Rehabilitation [NA]
A clinical trial evaluating how different types of focus instructions during rehabilitation affect outcomes in people with Parkinson disease…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Study on the Incidence of Malignant Neoplasms in Patients with Parkinson's Disease and Heterozygous Mutation of the GBA Gene
A clinical trial is investigating the incidence of malignant neoplasms in patients with idiopathic Parkinson's disease who carry a heterozyg…
-
FDA approval · 2025-02-11FDA Approved: BENZTROPINE MESYLATE — Original Application (QUAGEN PHARMACEUTICALS LLC)
The FDA approved the original application for benztropine mesylate (generic) from Quagen Pharmaceuticals LLC. It is indicated for Parkinson'…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Preparing Patient-Caregiver Dyads with Parkinson's Disease for Future Decision Making [NA]
A completed Purdue University study focusing on preparing Parkinson disease patient-caregiver dyads for future decision making.
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: The Effect of Amantadine as add-on Therapy for Motor Fluctuations in Advanced Parkinson's Disease: a Randomized Double-blinded Placebo-controlled Trial [Phase 2]
Phase 2 randomized double-blind trial evaluating amantadine as add-on therapy for motor fluctuations in advanced Parkinson's disease; curren…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Tenapanor in Synucleinopathy-Related Constipation [Phase 2]
A Phase 2 clinical trial evaluating tenapanor for constipation associated with synucleinopathies such as Parkinson's disease is currently re…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: A Study to Evaluate Efficacy, Safety and Tolerability of Hydroxychloroquine in Subjects With Parkinson's Disease [Phase 2]
This clinical trial update describes a Phase 2 study evaluating hydroxychloroquine for efficacy, safety, and tolerability in Parkinson's dis…
-
FDA approval · 2025-02-07FDA Approved: ONGENTYS — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for ONGENTYS (opicapone) submitted by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: A Phase I Study of TRN501 in Healthy Volunteers [Phase 1]
This update reports the completion of a Phase 1 study of TRN501 in healthy volunteers, with Parkinson disease listed as the condition.
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Effects of Action Observation Training and Motor Imagery Delivered by Telerehabilitation in Patients with Parkinson's Disease [NA]
A clinical trial is evaluating action observation training and motor imagery delivered via telerehabilitation in patients with Parkinson dis…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: Yoga for Mental Health in Parkinson's Patients [NA]
A completed clinical trial evaluating yoga for mental health in Parkinson's disease patients, focusing on stress, anxiety, and depression ou…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive Impairment [Phase 2]
Phase 2 study evaluating SAGE-718 in Parkinson's disease with cognitive impairment has completed, with results posted.
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: [18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating imaging tracers [18F]-MFBG, [123I]-MIBG, and [18F]-PE2I to differentiate Parkinson disease from multiple…
-
CLINICAL_TRIALS other · 2025-02-06Clinical Trial Update: Vortioxetine for Depressive Symptoms and Freezing of Gait in Parkinson Disease [Phase 4]
Phase 4 trial evaluating vortioxetine for depressive symptoms and freezing of gait in Parkinson disease is listed as not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Stimulation Parameters and Non-motor Symptoms in PD Treated With DBS [NA]
A clinical trial evaluating stimulation parameters and non-motor symptoms in Parkinson's disease patients treated with deep brain stimulatio…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Association of EEG Parameters with Postoperative Delirium in Patient's with Parkinson's Disease
This clinical trial investigates whether EEG parameters are associated with postoperative delirium in patients with Parkinson disease. The s…
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Home Based Tele-exercise for People With Chronic Neurological Impairments [NA]
A clinical trial (NCT04564495) evaluating home-based tele-exercise for people with chronic neurological impairments is currently active but …
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: In-home Cycling for Individuals With PD: Feasibility [NA]
A completed feasibility study evaluating in-home cycling for individuals with Parkinson disease, with results posted.
-
FDA approval · 2025-02-03FDA Approved: ONAPGO — Original Application (MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc)
FDA approved ONAPGO (apomorphine hydrochloride) from MDD US Operations, LLC (a subsidiary of Supernus Pharmaceuticals) under an Original NDA…
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: Development of Digital Services for Parkinson's Disease [NA]
Ongoing clinical trial at University of Exeter evaluating digital services for Parkinson's disease; recruitment is currently ongoing.